Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study
Objectives. Assessing the effectiveness and tolerability of medical cannabis (MC) treatment on Gilles de la Tourette syndrome (GTS) patients. Methods. We report on an open-label, prospective study on the effect of MC on adult GTS patients. MC mode of use was decided by the treating neurologist and t...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.1155/2022/5141773 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|